US Patent 10227410 Heterodimeric antibodies that bind CD3 and PSMA
Patent 10227410 was granted and assigned to Xencor on March, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 7, 2016
Date of Patent
March 12, 2019
Patent Applicant
Patent Application Number
15372360
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10227410 Heterodimeric antibodies that bind CD3 and PSMA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
